loadpatents
name:-0.044527053833008
name:-0.026998996734619
name:-0.0036771297454834
Parkin; Neil T. Patent Filings

Parkin; Neil T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Parkin; Neil T..The latest application filed is for "compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays".

Company Profile
3.24.34
  • Parkin; Neil T. - Belmont CA US
  • Parkin; Neil T. - Divonne FR
  • Parkin; Neil T. - Divonne Les Bains FR
  • Parkin; Neil T. - South San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors
Grant 10,202,658 - Parkin , et al. Feb
2019-02-12
Compositions and Methods for Evaluating Viral Receptor/Co-Receptor Usage and Inhibitors of Virus Entry Using Recombinant Virus Assays
App 20190025305 - Richman; Douglas ;   et al.
2019-01-24
Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
Grant 9,841,425 - Richman , et al. December 12, 2
2017-12-12
Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
App 20160209411 - Richman; Douglas ;   et al.
2016-07-21
Methods for determining the presence of antibodies blocking viral infection
Grant 9,175,355 - Richman , et al. November 3, 2
2015-11-03
Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs
Grant 8,637,252 - Gupta , et al. January 28, 2
2014-01-28
Methods and Compositions for Determining Hypersusceptibility of HIV-1 to Non-Nucleoside Reverse Transcriptase Inhibitors
App 20120283250 - Parkin; Neil T. ;   et al.
2012-11-08
Methods and Compositions for Determining Altered Susceptibility of HIV-1 to Anti-HIV Drugs
App 20120135395 - GUPTA; SOUMI ;   et al.
2012-05-31
Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors
Grant 8,178,291 - Parkin , et al. May 15, 2
2012-05-15
Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs
Grant 8,071,284 - Gupta , et al. December 6, 2
2011-12-06
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
App 20110229906 - Parkin; Neil T. ;   et al.
2011-09-22
Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
Grant 7,993,824 - Chappey , et al. August 9, 2
2011-08-09
Methods For Determining The Presence Of Antibodies Blocking Viral Infection
App 20110033836 - RICHMAN; DOUGLAS ;   et al.
2011-02-10
Methods and Compositions for Determining Altered Susceptibility of HIV-1 to Protease Inhibitor Treatment
App 20100227313 - Parkin; Neil T. ;   et al.
2010-09-09
Method For Determining Resistance Of Hiv To Protease Inhibitor Treatment
App 20100070184 - Parkin; Neil T. ;   et al.
2010-03-18
Methods and Compositions for Determining Hypersusceptibility of HIV-1 to Non-Nucleoside Reverse Transcriptase Inhibitors
App 20090208925 - Parkin; Neil T. ;   et al.
2009-08-20
Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir
Grant 7,553,618 - Parkin , et al. June 30, 2
2009-06-30
Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs
App 20090136915 - Gupta; Soumi ;   et al.
2009-05-28
Methods And Compositions For Determining Resistance Of Hiv-1 To Protease Inhibitors
App 20090087841 - Parkin; Neil T.
2009-04-02
Method for Determining Resistance of Hiv to Nucleoside Reverse Transcriptase Inhibitor Treatment
App 20080293038 - Parkin; Neil T. ;   et al.
2008-11-27
Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
Grant 7,384,734 - Parkin , et al. June 10, 2
2008-06-10
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
App 20080044810 - Parkin; Neil T. ;   et al.
2008-02-21
Method of evaluating a patient antibody response to envelope proteins of a virus
Grant 7,247,439 - Richman , et al. July 24, 2
2007-07-24
Methods of evaluating cell surface receptor binding of a patient derived population of viral envelope protein constructs
Grant 7,235,356 - Petropoulos , et al. June 26, 2
2007-06-26
Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
App 20070099296 - Parkin; Neil T. ;   et al.
2007-05-03
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
Grant 7,186,506 - Parkin , et al. March 6, 2
2007-03-06
Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs
Grant 7,169,551 - Petropoulos , et al. January 30, 2
2007-01-30
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
Grant 7,138,231 - Parkin , et al. November 21, 2
2006-11-21
Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs
Grant 7,097,970 - Petropoulos , et al. August 29, 2
2006-08-29
Methods Of Evaluating Cell Surface Receptor Binding Of A Patient Derived Population Of Viral Envelope Protein Constructs
App 20060183110 - Petropoulos; Christos J. ;   et al.
2006-08-17
Methods Of Evaluating Viral Entry Inhibitors Using Patient Derived Envelope Protein Constructs
App 20060160185 - Petropoulos; Christos J. ;   et al.
2006-07-20
Methods and compositions for determining resistance or susceptibility of HIV-1 to stavudine
App 20060094020 - Parkin; Neil T. ;   et al.
2006-05-04
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
App 20060035249 - Parkin; Neil T. ;   et al.
2006-02-16
Recombinant tryptophan mutants of influenza
Grant 6,974,686 - Parkin December 13, 2
2005-12-13
Method for determining reduced susceptibility of HIV to protease inhibitor treatment
App 20050214749 - Chappey, Colombe ;   et al.
2005-09-29
Compositions and methods for determining the replication capacity of a pathogenic virus
App 20050214750 - Parkin, Neil T. ;   et al.
2005-09-29
Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
App 20050214743 - Richman, Douglas ;   et al.
2005-09-29
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
Grant 6,869,759 - Parkin , et al. March 22, 2
2005-03-22
Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation
Grant 6,843,996 - Parkin , et al. January 18, 2
2005-01-18
Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
App 20040248084 - Chappey, Colombe ;   et al.
2004-12-09
Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
App 20040224307 - Parkin, Neil T. ;   et al.
2004-11-11
Novel Recombinant Tryptophan Mutants Of Influenza
App 20040131639 - Parkin, Neil T.
2004-07-08
Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
App 20040110125 - Petropoulos, Christos J. ;   et al.
2004-06-10
Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
App 20040106106 - Parkin, Neil T. ;   et al.
2004-06-03
Compositions and methods for determining the replication capacity of a pathogenic virus
App 20040063191 - Huang, Wei ;   et al.
2004-04-01
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
App 20030108857 - Parkin, Neil T. ;   et al.
2003-06-12
Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
App 20030028011 - Parkin, Neil T. ;   et al.
2003-02-06
Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
App 20020182592 - Petropoulos, Christos J. ;   et al.
2002-12-05
Novel recombinant tryptophan mutants of influenza
App 20020119445 - Parkin, Neil T.
2002-08-29
Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
App 20020094522 - Whitcomb, Jeannette ;   et al.
2002-07-18
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
App 20020064838 - Parkin, Neil T. ;   et al.
2002-05-30
Compositions And Methods For Determining Anti-viral Drug Susceptibility And Resistance And Anti-viral Drug Screening
App 20020034732 - CAPON, DANIEL J. ;   et al.
2002-03-21
Recombinant tryptophan mutants of influenza
Grant 6,322,967 - Parkin November 27, 2
2001-11-27
Recombinant tryptophan mutants of influenza
Grant 6,090,391 - Parkin July 18, 2
2000-07-18
Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
Grant 5,690,937 - Parkin , et al. November 25, 1
1997-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed